{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:32:40Z","timestamp":1787455960339,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study investigated the feasibility and safety of laparoscopic splenectomy conducted in the contexts of both laparoscopic secondary surgery for isolated recurrence in the spleen and primary laparoscopic cytoreductive surgery for advanced ovarian cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a perspective observational study including all consecutive patients with ovarian cancer who underwent laparoscopic splenectomy as part of primary cytoreductive procedures for advanced stage ovarian cancer or secondary surgery for isolated splenic recurrence between January 2016 and May 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We enrolled 13 consecutive patients, candidate to laparoscopic splenectomy as part of primary cytoreductive procedures for advanced stage ovarian cancer (6 patients) or secondary surgery for isolated splenic recurrence of platinum-sensitive ovarian cancer (7 patients). Median operative time (509\u00a0min [range, 200\u2013845]) for primary cytoreductive surgery varied according to surgical complexity depending on the extensiveness of the disease. Median operative time for secondary surgery for isolated splenic metastasis was 253\u00a0min (90\u2013380). Only 1 patient with isolated splenic recurrence required conversion to an open approach. No intraoperative complication occurred, and no intraoperative blood transfusions were required. Median hospital stay was 3\u00a0days (range, 2\u20135) for isolated recurrence and 9\u00a0days (7\u201318) for primary cytoreductive surgery. Complete tumor resection was achieved in all patients. Median time from surgery to adjuvant chemotherapy was 16\u00a0days (7\u201324). All six patients who underwent laparoscopic splenectomy during primary cytoreductive surgery remain alive, four of whom exhibit no evidence of disease (median follow-up 25\u00a0months [4\u201336]). Among patients who underwent laparoscopic splenectomy during secondary surgery for isolated splenic relapse, all patients are alive and only one had a central diaphragmatic relapse 2\u00a0years after surgery (median follow-up 17\u00a0months ([5\u201348\u00a0months]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The laparoscopic approach to splenectomy is feasible and safe both in patients undergoing primary cytoreductive surgery for advanced stage disease and those with isolated recurrence of ovarian cancer, without compromising survival and allowing early initiation of postoperative systemic chemotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-021-01368-z","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T13:02:55Z","timestamp":1635426175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique"],"prefix":"10.1186","volume":"21","author":[{"given":"Antonio","family":"Macci\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Lavra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Chiappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"1368_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/gyno.2000.5800","volume":"77","author":"LM Chen","year":"2000","unstructured":"Chen LM, Leuchter RS, Lagasse LD, Karlan BY. Splenectomy and surgical cytoreduction for ovarian cancer. Gynecol Oncol. 2000;77:362\u20138.","journal-title":"Gynecol Oncol"},{"key":"1368_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","volume":"103","author":"EL Eisenhauer","year":"2006","unstructured":"Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol. 2006;103:1083\u201390.","journal-title":"Gynecol Oncol"},{"key":"1368_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/IGC.0b013e3182571479","volume":"22","author":"I Zapardiel","year":"2012","unstructured":"Zapardiel I, Peiretti M, Zanagnolo V, Biffi R, Bocciolone L, Landoni F, et al. Splenectomy as part of primary cytoreductive surgery for advanced ovarian cancer: a retrospective cohort study. Int J Gynecol Cancer. 2012;22:968\u201373.","journal-title":"Int J Gynecol Cancer"},{"key":"1368_CR4","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.2147\/CMAR.S172687","volume":"10","author":"H Sun","year":"2018","unstructured":"Sun H, Bi X, Cao D, Wu M, Pan L, Huang H, et al. Splenectomy during cytoreductive surgery in epithelial ovarian cancer. Cancer Manag Res. 2018;10:3473\u201382.","journal-title":"Cancer Manag Res"},{"key":"1368_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jmig.2013.04.027","volume":"20","author":"FR Nezhat","year":"2013","unstructured":"Nezhat FR, Pejovic T, Finger TN, Khalil SS. Role of minimally invasive surgery in ovarian cancer. J Minim Invasive Gynecol. 2013;20:754\u201365.","journal-title":"J Minim Invasive Gynecol"},{"key":"1368_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","volume":"102","author":"PM Magtibay","year":"2006","unstructured":"Magtibay PM, Adams PB, Silverman MB, Cha SS, Podratz KC. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol. 2006;102:369\u201374.","journal-title":"Gynecol Oncol"},{"key":"1368_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jmig.2016.01.001","volume":"23","author":"V Gallotta","year":"2016","unstructured":"Gallotta V, Nero C, Lodoli C, Chiantera V, Pacelli F, Fagotti A, et al. Laparoscopic splenectomy for secondary cytoreduction in ovarian cancer patients with localized spleen recurrence: feasibility and technique. J Minim Invasive Gynecol. 2016;23:425\u20138.","journal-title":"J Minim Invasive Gynecol"},{"key":"1368_CR8","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s00464-013-3390-9","volume":"28","author":"V Gallotta","year":"2014","unstructured":"Gallotta V, Fagotti A, Fanfani F, Ferrandina G, Nero C, Costantini B, et al. Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. Surg Endosc. 2014;28:1808\u201315.","journal-title":"Surg Endosc"},{"key":"1368_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ygyno.2013.01.015","volume":"129","author":"JF Magrina","year":"2013","unstructured":"Magrina JF, Cetta RL, Chang YH, Guevara G, Magtibay PM. Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy. Gynecol Oncol. 2013;129:336\u201340.","journal-title":"Gynecol Oncol"},{"key":"1368_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ygyno.2005.10.037","volume":"101","author":"DS Chi","year":"2006","unstructured":"Chi DS, Abu-Rustum NR, Sonoda Y, Im HB, Jhamb N, D\u2019Angelica M, et al. Laparoscopic and handassisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. Gynecol Oncol. 2006;101:224\u20137.","journal-title":"Gynecol Oncol"},{"key":"1368_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ygyno.2014.05.007","volume":"134","author":"PF Escobar","year":"2014","unstructured":"Escobar PF, Levinson KL, Magrina J, Martino MA, Barakat RR, Fader AN, et al. Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: a multi-institutional study. Gynecol Oncol. 2014;134:253\u20136.","journal-title":"Gynecol Oncol"},{"key":"1368_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00019509-199802000-00012","volume":"8","author":"PJ Klinger","year":"1998","unstructured":"Klinger PJ, Smith SL, Abendstein BJ, Hinder RA. Hand-assisted laparoscopic splenectomy for isolated splenic metastasis from an ovarian carcinoma: a case report with review of the literature. Surg Laparosc Endosc. 1998;8:49\u201354.","journal-title":"Surg Laparosc Endosc"},{"key":"1368_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijscr.2019.10.044","volume":"65","author":"D Dimitrov","year":"2019","unstructured":"Dimitrov D. Laparoscopic splenectomy for solitary splenic metastasis in patients with previous open surgery\u2014case series. Int J Surg Case Rep. 2019;65:83\u20136.","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"1368_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13256-018-1673-4","volume":"12","author":"K Yasuda","year":"2018","unstructured":"Yasuda K, Yoshimura T, Kitade H, Yanagida H, Hosaka N. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report. J Med Case Rep. 2018;12(1):132.","journal-title":"J Med Case Rep"},{"key":"1368_CR15","first-page":"1411","volume":"44","author":"T Nagata","year":"2017","unstructured":"Nagata T, Nakamura K, Sougawa A, Mochizuki S, Nakase Y, Kitai S, Inaba S. Solitary splenic hilar nodes metastasis from ovarian cancer managed by splenectomy with pancreas tail. Gan To Kagaku Ryoho. 2017;44:1411\u20133.","journal-title":"Gan To Kagaku Ryoho"},{"key":"1368_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4293\/108680810X12785289143990","volume":"14","author":"FR Nezhat","year":"2010","unstructured":"Nezhat FR, DeNoble SM, Liu CS, Cho JE, Brown DN, Chuang L, et al. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers. JSLS. 2010;14:155\u201368.","journal-title":"JSLS"},{"key":"1368_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien\u2013Dindo classification of surgical complications: 5-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg"},{"key":"1368_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366:610\u20138.","journal-title":"N Engl J Med"},{"key":"1368_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ygyno.2013.08.005","volume":"131","author":"A Fagotti","year":"2013","unstructured":"Fagotti A, Vizzielli G, Fanfani F, Costantini B, Ferrandina G, Gallotta V, et al. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience. Gynecol Oncol. 2013;131:341\u20136.","journal-title":"Gynecol Oncol"},{"key":"1368_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ygyno.2015.07.095","volume":"139","author":"M Petrillo","year":"2015","unstructured":"Petrillo M, Vizzielli G, Fanfani F, Gallotta V, Cosentino F, Chiantera V, et al. Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept. Gynecol Oncol. 2015;139:5\u20139.","journal-title":"Gynecol Oncol"},{"key":"1368_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248\u201359.","journal-title":"J Clin Oncol"},{"issue":"2 Suppl","key":"1368_CR22","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.ygyno.2008.07.053","volume":"111","author":"SM Kehoe","year":"2008","unstructured":"Kehoe SM, Eisenhauer EL, Chi DS. Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy\/resection, splenectomy, and distal pancreatectomy. Gynecol Oncol. 2008;111(2 Suppl):S51\u20135.","journal-title":"Gynecol Oncol"},{"key":"1368_CR23","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1245\/s10434-011-1661-z","volume":"18","author":"CK McCann","year":"2011","unstructured":"McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, et al. Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer. Ann Surg Oncol. 2011;18:2912\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1368_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ygyno.2005.08.036","volume":"100","author":"SM Eisenkop","year":"2006","unstructured":"Eisenkop SM, Spirtos NM, Lin WC. Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer. Gynecol Oncol. 2006;100:344\u2013434.","journal-title":"Gynecol Oncol"},{"key":"1368_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00404-004-0612-3","volume":"271","author":"T Bilgin","year":"2005","unstructured":"Bilgin T, Ozerkan K, Ozan H. Splenectomy in cytoreductive surgery for advanced ovarian cancer. Arch Gynecol Obstet. 2005;271:329\u201331.","journal-title":"Arch Gynecol Obstet"},{"key":"1368_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/gyno.1995.1218","volume":"58","author":"JL Nicklin","year":"1995","unstructured":"Nicklin JL, Copeland LJ, O\u2019Toole RV, Lewandowski GS, Vaccarello L, Havenar LP. Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol. 1995;58:244\u20137.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1368_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1048-891X.2004.014940.x","volume":"14","author":"A Ayhan","year":"2004","unstructured":"Ayhan A, Al RA, Baykal C, Demirtas E, Ayhan A, Y\u00fcce K. The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer. Int J Gynecol Cancer. 2004;14(1):51\u20136.","journal-title":"Int J Gynecol Cancer"},{"key":"1368_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00404-020-05684-2","volume":"302","author":"G Sozzi","year":"2020","unstructured":"Sozzi G, Petrillo M, Berretta R, Capozzi VA, Paci G, Music\u00f2 G, et al. Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience. Arch Gynecol Obstet. 2020;302:707\u201314.","journal-title":"Arch Gynecol Obstet"},{"key":"1368_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jmig.2009.01.007","volume":"16","author":"CS Liu","year":"2009","unstructured":"Liu CS, Nagarsheth NP, Nezhat FR. Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer? J Minim Invasive Gynecol. 2009;16:250\u201362.","journal-title":"J Minim Invasive Gynecol"},{"key":"1368_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ygyno.2011.06.020","volume":"123","author":"J Fanning","year":"2011","unstructured":"Fanning J, Yacoub E, Hojat R. Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: success, morbidity and survival. Gynecol Oncol. 2011;123:47\u20139.","journal-title":"Gynecol Oncol"},{"key":"1368_CR31","doi-asserted-by":"publisher","first-page":"113239","DOI":"10.18632\/oncotarget.22573","volume":"8","author":"H Liang","year":"2017","unstructured":"Liang H, Guo H, Zhang C, Zhu F, Wu Y, Zhang K, et al. Feasibility and outcome of primary laparoscopic cytoreductive surgery for advanced epithelial ovarian cancer: a comparison to laparotomic surgery in retrospective cohorts. Oncotarget. 2017;8:113239\u201347.","journal-title":"Oncotarget"},{"key":"1368_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.23736\/S0026-4806.19.06132-9","volume":"110","author":"S Gueli Alletti","year":"2019","unstructured":"Gueli Alletti S, Capozzi VA, Rosati A, De Blasis I, Cianci S, Vizzielli G, et al. Laparoscopy vs laparotomy for advanced ovarian cancer: a systematic review of the literature. Minerva Med. 2019;110:341\u201357.","journal-title":"Minerva Med"},{"key":"1368_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.23736\/S0026-4784.20.04605-5","volume":"72","author":"M La Russa","year":"2020","unstructured":"La Russa M, Liakou CG, Akrivos N, Turnbull HL, Duncan TJ, Nieto JJ, et al. Learning curve for gynecological oncologists in performing upper abdominal surgery. Minerva Ginecol. 2020;72:325\u201331.","journal-title":"Minerva Ginecol"},{"key":"1368_CR34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jmig.2017.12.007","volume":"25","author":"S Gueli Alletti","year":"2018","unstructured":"Gueli Alletti S, Vizzielli G, Lafuenti L, Costantini B, Fagotti A, Fedele C, et al. Single-institution propensity-matched study to evaluate the psychological effect of minimally invasive interval debulking surgery versus standard laparotomic treatment: from body to mind and back. J Minim Invasive Gynecol. 2018;25:816\u201322.","journal-title":"J Minim Invasive Gynecol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-021-01368-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-021-01368-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-021-01368-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T13:03:41Z","timestamp":1635426221000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-021-01368-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1186\/s12893-021-01368-z","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Italian Regulatory Agency for observational studies not involving drugs and considering that the surgical procedure used were not experimental, the study has been notified and approved by the Institutional Independent Ethics Committee of the \u201cAzienda Ospedaliera Universitaria di Cagliari\u201d, Cagliari, Italy. Written informed consent was obtained from each patient for surgery as study participation. The study was performed in accordance with the principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from each patient for the publication of the case report and the accompanying videos\/images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}